Morning hypercoagulability and hypofibrinolysis: Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin- plasmin inhibitor complex

Circulation

Volumn 96, Issue 1, 1997, Pages 19-21

  Kapiotis, Stylianos ^b   Jilma, Bernd ^b   Quehenberger, Peter ^b   Ruzicka, Katharina ^b   Handler, Sylvia ^b   Speiser, Wolfgang ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Circadian rhythm; Coagulation; Fibrinolysis

Indexed keywords

ANTIPLASMIN; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; LIPID; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CIRCADIAN RHYTHM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; HYPERCOAGULABILITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030744572     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.1.19     Document Type: Article

References (24)

1. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, Selwyn AP. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation. 1987;75:395-400.
2. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E, and the MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:1315-1322.
3. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. Circadian variation in the frequency of sudden cardiac death. Circulation. 1987;75:131-138.
4. Kelly Hayes M, Wolf PA, Kase CS, Brand FN, McGuirk JM, D'Agostino RB. Temporal patterns of stroke onset: the Framingham Study. Stroke. 1995;26:1343-1347.
5. Colantonio D, Casale R, Abruzzo BP, Lorenzetti G, Pasqualetti P. Circadian distribution in fatal pulmonary thromboembolism. Am J Cardiol. 1989;64:403-404.
6. Haus E, Cusulos M, Sackett Lundeen L, Swoyer J. Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects. Chronobiol Int. 1990;7:203-216.
7. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation. 1989;79:101-106.
8. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993;81:734-744.
9. Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood. 1987;70:343-350.
10. Harpel PC. α2-Plasmin inhibitor and α2-macroglobulin-plasmin complexes in plasma: quantitation by an enzyme-linked differential antibody immunosorbent assay. J Clin Invest. 1981;68:46-55.
11. Jilma B, Eichler HG, Vondrovec B, Breiteneder H, Kyrle PA, Kitzweger E, Kapiotis S, Speiser W. Effects of desmopressin on circulating P-selectin. Br J Haematol. 1996;93:432-436.
12. Brezinski DA, Tofler GH, Muller JE, Pohjola Sintonen S, Willich SN, Schafer AI, Czeisler CA, Williams GH. Morning increase in platelet aggregability: association with assumption of the upright posture. Circulation. 1988;78:35-40.
13. Ehrly AM, Jung G. Circadian rhythm of human blood viscosity. Biorheology. 1973;10:577-583.
14. Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L. Population correlates of coagulation factor VII: importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vasc Biol. 1996;16: 1170-1176.
15. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A. 1989;86:2839-2843.
16. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest. 1983;71:1893-1896.
17. Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Thromb Haemost. 1996; 76:729-734.
18. Kapur R, Hoffmann CJ, Bhushan V, Hultin MB. Postprandial elevation of activated factor VII in young adults. Arterioscler Thromb Vasc Biol. 1996;16:1327-1332.
19. Rosenfeld BA, Faraday N, Campbell D, Sakima D, Bell W. The effects of bed rest on circadian changes in hemostasis. Thromb Haemost. 1994;72:281-284.
20. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg RD. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb Haemost. 1996;76:767-771.
21. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79: 733-743.
22. Decousus HA, Croze M, Levi FA, Jaubert JG, Perpoint BM, De Bonadona JF, Reinberg A, Queneau PM. Circadian changes in anticoagulant effect of heparin infused at a constant rate. Br Med J Clin Res Ed. 1985;290:341-344.
23. Krulder JW, Van den Besselaar AM, Van der Meer FJ, Meinders AE, Briet E. Diurnal changes in heparin effect during continuous constant-rate infusion: a study in nine patients with venous thromboembolism. J Intern Med. 1994;235:411-417.
24. Braunwald E. Morning resistance to thrombolytic therapy. Circulation. 1995;91:1604-1606.